CR
Cresco Labs Inc.
CRLBF · OTC
$0.75 +2.67% (+$0.02)
1M -10.86%
Market Cap $265.5M
P/E Ratio -
Div. Yield -
ROE 28.27%
Bulios Fair Price
$0.41
45.3% downside
Trenutna cena
$0.75
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CRLBF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
79 /100
Cheap EV/EBITDA 7.92x
P/FCF 26.18x
P/S 0.41x
Growth
0 /100
Declining Rev. growth 7.48%
Book val. growth 18.47%
EPS growth N/A
Profitability
37 /100
Moderate Gross margin 48.41%
FCF margin 1.56%
Net margin 15.88%
Quality
19 /100
Poor ROIC 6.02%
Asset turnover 0.52x
ROE 28.27%
Debt
25 /100
High Debt/Equity 1.65x
Net debt/EBITDA 5.37x
Current ratio 1.78x
Stability
35 /100
Moderate Beta 1.72x
Profitable years 0
Rev. volatility 1.29%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CRLBF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Charles Bachtell
Employees
2,900
Headquarters
Chicago
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report